Sponsors (6)
The bill would improve public-health protection and regulatory clarity by setting federal contamination thresholds and retaining federal control over contaminated poppy seeds, but it imposes greater testing/compliance costs and legal risks that could harm small businesses, disrupt supply, raise consumer prices, and potentially criminalize inadvertent possession.
Consumers (including patients, women, military personnel, and low-income individuals) will face lower risk of accidental opioid exposure because federal contamination thresholds let regulators prohibit or remove adulterated poppy seeds from interstate commerce, reducing hospitalizations, false positive drug tests, and deaths.
State and federal regulators and businesses gain clearer, consistent authority and standards (HHS/DEA clarification and a federal contamination standard), improving enforcement certainty and reducing patchwork state-level rules.
Keeping poppy seeds that test positive for opioid alkaloids under federal control helps prevent diversion and illicit distribution of opioids.
Farmers, seed suppliers, small-business-owners, bakers, and retailers face increased testing and compliance costs, higher risk of recalls or seizures, and potential lost sales — economic burdens that could force some suppliers out of the market or raise prices for consumers.
Individuals who unknowingly consume contaminated poppy seeds (including patients with chronic conditions) could face criminal or administrative consequences if possession of contaminated seeds is treated as a controlled substance, raising justice and fairness concerns.
If contamination limits are set very low, certain imports or domestic lots could be effectively barred from the market, causing supply disruptions that reduce availability and further increase prices for bakers and consumers.
Based on analysis of 4 sections of legislative text.
Directs HHS to set contamination limits for morphine, codeine, and other alkaloids in poppy seeds, declaring seeds above the limits adulterated and barred from interstate commerce, with rule deadlines.
Introduced April 2, 2025 by Steve Womack · Last progress April 2, 2025
Requires the Department of Health and Human Services (HHS) to set contamination limits for morphine, codeine, and other opium-alkaloid compounds in poppy seeds and to declare seeds that exceed those limits as adulterated under the Federal Food, Drug, and Cosmetic Act. HHS must publish a proposed rule within 1 year of enactment and a final rule within 2 years. The law also makes clear that poppy seeds contaminated with those compounds remain subject to the Controlled Substances Act where applicable.